13048_2020_703_MOESM3_ESM.tif (1.79 MB)
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
figure
posted on 2020-08-22, 03:34 authored by Kuo-Chang Wen, Pi-Lin Sung, Alexander T. H. Wu, Ping-Chieh Chou, Jun-Hung Lin, Chi-Ying F. Huang, Sai-Ching J. Yeung, Mong-Hong LeeAdditional file 3: Figure S3. Metformin at a Clinically Relevant Dosage Inhibits Human Ovarian Cancer Growth. a Growth of human ovarian cancer cells (SKOV3) incubated f with micromolar concentrations of metformin (0.5 mM) for several days. *: p < 0.05, two-way ANOVA. b The log (CI) values following a 48-h exposure to combination treatment of metformin and carboplatin, reflecting the synergistic effects against the human ovarian cancer cell line ES-2.
